Back to Search Start Over

Fresenius Kabi Introduces First-Ever Generic for Foscavir[R] (Foscarnet Sodium) Injection

Source :
Business Wire. March 15, 2021
Publication Year :
2021

Abstract

Increasing access and lowering costs for medicine used to treat immune-compromised patients LAKE ZURICH, Ill. -- Fresenius Kabi announced today the immediate availability in the United States of Foscarnet Sodium [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
Business Wire
Publication Type :
News
Accession number :
edsgcl.655003002